Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.

Try Elite for Free

O

OLMA

Olema Pharmaceuticals Inc

7.07

Nov 02 • 3:59 PM ET +0.07 (1.00%)

7.07

Aftermarket • 7:30 PM ET 0.00 (0.00%)

Healthcare Biotechnology USA Small NASD

Peers: ARVN CELC RLAY LLY AZN PFE ATOS IDYA ELVN NVS

| Held by: VTI XBI IWM VXF IWN DFAS VTWO IBB FESM SCHA

Scroll to Statements

Index	RUT
Market Cap	618.60M
Enterprise Value	161.19M
Income	-204.57M
Sales	0.00M
Book/sh	4.92
Cash/sh	5.27
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	131
IPO	Nov 19, 2020

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	1.44
P/C	1.34
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	8.86
Current Ratio	8.86
Debt/Eq	0.01
LT Debt/Eq	0.01
Option/Short	Yes / Yes

EPS (ttm)	-2.12
EPS next Y	-2.66
EPS next Q	-0.64
EPS this Y	-28.05%
EPS next Y	-11.21%
EPS next 5Y	-6.23%
EPS past 3/5Y	10.68% -25.06%
Sales past 3/5Y	- -
EPS Y/Y TTM	-10.16%
Sales Y/Y TTM	-
EPS Q/Q	-18.14%
Sales Q/Q	-
Earnings	Aug 10 AMC
EPS/Sales Surpr.	-10.61% -

Insider Own	19.66%
Insider Trans	-0.15%
Inst Own	100.64%
Inst Trans	0.56%
ROA	-47.10%
ROE	-52.74%
ROIC	-47.18%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-1.48%
SMA50	-19.34%
SMA200	-49.20%
Trades

Shs Outstand	87.45M
Shs Float	70.29M
Short Float	22.31%
Short Ratio	13.28
Short Interest	15.68M
52W High	36.26 -80.50%
52W Low	6.24 13.39%
Volatility	8.01% 6.81%
ATR (14)	0.50
RSI (14)	41.12
Beta	2.13
Rel Volume	0.95
Avg Volume	1.18M
Volume	1,118,800

Perf Week	6.80%
Perf Month	-14.04%
Perf Quarter	-39.88%
Perf Half Y	-51.67%
Perf YTD	-71.72%
Perf Year	-21.18%
Perf 3Y	-55.08%
Perf 5Y	-73.65%
Perf 10Y	-
Recom	1.17
Target Price	36.50
Prev Close	7.00
Price	7.07
Change %	1.00%

Affiliate • Advertise • APIs • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)